Pozelimab (REGN3918) is a fully human IgG4 anti-C5 monoclonal antibody. Pozelimab binds to C5 and C5 variants with high affinity and blocks complement-mediated hemolysis. Pozelimab can be used for the research of complement-mediated diseases.
Purity:
>99.0%
CAS Number:
[2096328-94-6]
Target:
Complement System
* VAT and and shipping costs not included. Errors and price changes excepted